Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Trial of Adjuvant Therapy With an Alpha-lactalbumin Vaccine in Patients With Non-Metastatic Triple-Negative Breast Cancer at High Risk of Recurrence

NCT04674306 is registered in ClinicalTrials.gov with George T. Budd as lead sponsor.

NCT NCT04674306
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04674306 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Trial of Adjuvant Therapy With an Alpha-lactalbumin Vaccine in Patients With Non-Metastatic Triple-Negative Breast Cancer at High Risk of Recurrence
Lead sponsor
George T. Budd
Phase
Phase 1
Overall status
Completed
Start date
October 1, 2021
Completion date
December 29, 2025
Enrollment
35 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pathologic stage iia-iiic triple-negative breast cancer, residual disease, tnbc - triple-negative breast cancer